CA1063131A - Synthetic alkyl esters of phospholipid acid, structural analogs thereof and a process for their manufacture and their use - Google Patents
Synthetic alkyl esters of phospholipid acid, structural analogs thereof and a process for their manufacture and their useInfo
- Publication number
- CA1063131A CA1063131A CA232,800A CA232800A CA1063131A CA 1063131 A CA1063131 A CA 1063131A CA 232800 A CA232800 A CA 232800A CA 1063131 A CA1063131 A CA 1063131A
- Authority
- CA
- Canada
- Prior art keywords
- reacted
- acid
- phosphoric acid
- organic solvent
- ester
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000000034 method Methods 0.000 title claims abstract description 41
- 239000002253 acid Substances 0.000 title claims abstract description 19
- 125000005907 alkyl ester group Chemical group 0.000 title claims abstract description 14
- 150000003904 phospholipids Chemical class 0.000 title claims abstract description 13
- 238000004519 manufacturing process Methods 0.000 title abstract description 5
- 150000003839 salts Chemical class 0.000 claims abstract description 8
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 claims description 39
- 150000001875 compounds Chemical class 0.000 claims description 32
- 238000006243 chemical reaction Methods 0.000 claims description 24
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 22
- 239000000126 substance Substances 0.000 claims description 21
- 238000002360 preparation method Methods 0.000 claims description 18
- 239000003960 organic solvent Substances 0.000 claims description 15
- 238000006366 phosphorylation reaction Methods 0.000 claims description 13
- 239000003795 chemical substances by application Substances 0.000 claims description 11
- -1 1,2,3,4,5-pentapalmitoyl-D-mannitol Chemical compound 0.000 claims description 10
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 10
- 230000026731 phosphorylation Effects 0.000 claims description 10
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 9
- 125000000217 alkyl group Chemical group 0.000 claims description 9
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 9
- 125000003118 aryl group Chemical group 0.000 claims description 9
- 125000004432 carbon atom Chemical group C* 0.000 claims description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerol Substances OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 9
- NBIIXXVUZAFLBC-UHFFFAOYSA-N phosphoric acid Substances OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 9
- 229920006395 saturated elastomer Polymers 0.000 claims description 9
- 150000003138 primary alcohols Chemical class 0.000 claims description 6
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 claims description 6
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 4
- 230000007717 exclusion Effects 0.000 claims description 3
- 229910052736 halogen Inorganic materials 0.000 claims description 3
- 150000002367 halogens Chemical group 0.000 claims description 3
- PHNWGDTYCJFUGZ-UHFFFAOYSA-N hexyl dihydrogen phosphate Chemical compound CCCCCCOP(O)(O)=O PHNWGDTYCJFUGZ-UHFFFAOYSA-N 0.000 claims description 3
- DCKVNWZUADLDEH-UHFFFAOYSA-N sec-butyl acetate Chemical compound CCC(C)OC(C)=O DCKVNWZUADLDEH-UHFFFAOYSA-N 0.000 claims description 3
- 239000002904 solvent Substances 0.000 claims description 3
- 150000002440 hydroxy compounds Chemical class 0.000 claims description 2
- QWHKYVBQPAUEPF-UHFFFAOYSA-N 2,3-dioctoxypropan-1-ol Chemical compound CCCCCCCCOCC(CO)OCCCCCCCC QWHKYVBQPAUEPF-UHFFFAOYSA-N 0.000 claims 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims 3
- KBPLFHHGFOOTCA-UHFFFAOYSA-N 1-Octanol Chemical compound CCCCCCCCO KBPLFHHGFOOTCA-UHFFFAOYSA-N 0.000 claims 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims 2
- ZSIAUFGUXNUGDI-UHFFFAOYSA-N hexan-1-ol Chemical compound CCCCCCO ZSIAUFGUXNUGDI-UHFFFAOYSA-N 0.000 claims 2
- 239000000376 reactant Substances 0.000 claims 2
- JFBCSFJKETUREV-LJAQVGFWSA-N 1,2-ditetradecanoyl-sn-glycerol Chemical compound CCCCCCCCCCCCCC(=O)OC[C@H](CO)OC(=O)CCCCCCCCCCCCC JFBCSFJKETUREV-LJAQVGFWSA-N 0.000 claims 1
- RFTQYAISEPTPPC-UHFFFAOYSA-N OCC(O)CO.C1(CCCCCCCCCCCCCC1)C(=O)C1CCCCCCCCCCCCCC1 Chemical compound OCC(O)CO.C1(CCCCCCCCCCCCCC1)C(=O)C1CCCCCCCCCCCCCC1 RFTQYAISEPTPPC-UHFFFAOYSA-N 0.000 claims 1
- 230000002730 additional effect Effects 0.000 claims 1
- 125000004429 atom Chemical group 0.000 claims 1
- 150000007530 organic bases Chemical class 0.000 claims 1
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 12
- 229960001701 chloroform Drugs 0.000 description 10
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 9
- 159000000000 sodium salts Chemical class 0.000 description 9
- 239000007795 chemical reaction product Substances 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 238000003756 stirring Methods 0.000 description 8
- 238000009835 boiling Methods 0.000 description 7
- 150000002009 diols Chemical class 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 6
- 150000001298 alcohols Chemical class 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 5
- 238000000605 extraction Methods 0.000 description 5
- 235000011187 glycerol Nutrition 0.000 description 5
- 229910052739 hydrogen Inorganic materials 0.000 description 5
- 150000002576 ketones Chemical class 0.000 description 5
- 239000012528 membrane Substances 0.000 description 5
- 229910052698 phosphorus Inorganic materials 0.000 description 5
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
- 229910052794 bromium Inorganic materials 0.000 description 4
- 150000001924 cycloalkanes Chemical class 0.000 description 4
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 3
- 239000000460 chlorine Substances 0.000 description 3
- 238000004821 distillation Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 239000003925 fat Substances 0.000 description 3
- 235000019197 fats Nutrition 0.000 description 3
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 3
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 239000003208 petroleum Substances 0.000 description 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 230000035484 reaction time Effects 0.000 description 3
- 238000004809 thin layer chromatography Methods 0.000 description 3
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 2
- UDIPIOHLDFSMLR-UHFFFAOYSA-N 2-phenylmethoxypropane-1,3-diol Chemical compound OCC(CO)OCC1=CC=CC=C1 UDIPIOHLDFSMLR-UHFFFAOYSA-N 0.000 description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 2
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 2
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 150000001299 aldehydes Chemical class 0.000 description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 2
- WERYXYBDKMZEQL-UHFFFAOYSA-N butane-1,4-diol Chemical compound OCCCCO WERYXYBDKMZEQL-UHFFFAOYSA-N 0.000 description 2
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 125000004122 cyclic group Chemical group 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000001804 emulsifying effect Effects 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 239000011737 fluorine Substances 0.000 description 2
- 229910052731 fluorine Inorganic materials 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 125000001624 naphthyl group Chemical group 0.000 description 2
- DMCJFWXGXUEHFD-UHFFFAOYSA-N pentatriacontan-18-one Chemical compound CCCCCCCCCCCCCCCCCC(=O)CCCCCCCCCCCCCCCCC DMCJFWXGXUEHFD-UHFFFAOYSA-N 0.000 description 2
- 230000003389 potentiating effect Effects 0.000 description 2
- 239000000344 soap Substances 0.000 description 2
- 239000001632 sodium acetate Substances 0.000 description 2
- 235000017281 sodium acetate Nutrition 0.000 description 2
- 239000012265 solid product Substances 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- 229940086542 triethylamine Drugs 0.000 description 2
- 229940043375 1,5-pentanediol Drugs 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- LGZMUUBPTDRQQM-UHFFFAOYSA-N 10-Bromo-1-decanol Chemical compound OCCCCCCCCCCBr LGZMUUBPTDRQQM-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- USJDOLXCPFASNV-UHFFFAOYSA-N 9-bromononan-1-ol Chemical compound OCCCCCCCCCBr USJDOLXCPFASNV-UHFFFAOYSA-N 0.000 description 1
- 101100087530 Caenorhabditis elegans rom-1 gene Proteins 0.000 description 1
- 101100476962 Drosophila melanogaster Sirup gene Proteins 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 101100305983 Mus musculus Rom1 gene Proteins 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- ALQSHHUCVQOPAS-UHFFFAOYSA-N Pentane-1,5-diol Chemical compound OCCCCCO ALQSHHUCVQOPAS-UHFFFAOYSA-N 0.000 description 1
- 102000015439 Phospholipases Human genes 0.000 description 1
- 108010064785 Phospholipases Proteins 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 150000001241 acetals Chemical class 0.000 description 1
- 238000005903 acid hydrolysis reaction Methods 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 125000003158 alcohol group Chemical group 0.000 description 1
- GZCGUPFRVQAUEE-SLPGGIOYSA-N aldehydo-D-glucose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O GZCGUPFRVQAUEE-SLPGGIOYSA-N 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- 238000002306 biochemical method Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 150000008280 chlorinated hydrocarbons Chemical class 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- HEBKCHPVOIAQTA-NGQZWQHPSA-N d-xylitol Chemical compound OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 description 1
- 238000006264 debenzylation reaction Methods 0.000 description 1
- TXEDBPFZRNBYGP-UHFFFAOYSA-N dimethyl hydrogen phosphate;methyl dihydrogen phosphate Chemical compound COP(O)(O)=O.COP(O)(=O)OC TXEDBPFZRNBYGP-UHFFFAOYSA-N 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 239000002360 explosive Substances 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 229940052308 general anesthetics halogenated hydrocarbons Drugs 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 150000008282 halocarbons Chemical class 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- FBPFZTCFMRRESA-UHFFFAOYSA-N hexane-1,2,3,4,5,6-hexol Chemical class OCC(O)C(O)C(O)C(O)CO FBPFZTCFMRRESA-UHFFFAOYSA-N 0.000 description 1
- XXMIOPMDWAUFGU-UHFFFAOYSA-N hexane-1,6-diol Chemical compound OCCCCCCO XXMIOPMDWAUFGU-UHFFFAOYSA-N 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 230000002101 lytic effect Effects 0.000 description 1
- 235000013310 margarine Nutrition 0.000 description 1
- 239000003264 margarine Substances 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 150000002482 oligosaccharides Polymers 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 125000006239 protecting group Chemical group 0.000 description 1
- 239000012429 reaction media Substances 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000000606 toothpaste Substances 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C07F9/10—Phosphatides, e.g. lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/55—Phosphorus compounds
- A61K8/553—Phospholipids, e.g. lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Biophysics (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Birds (AREA)
Abstract
SYNTHETIC ALKYL ESTERS OF PHOSPHOLIPID ACID, STRUCTURAL ANALOGS
THEREOF AND A PROCESS FOR THEIR MANUFACTURE AND THEIR USE
Abstract of the Disclosure:
Synthetic alkylesters of phospholipid acid, the structu-ral analogues thereof, their physiologically acceptable salts as well as a process for preparing them and their use.
THEREOF AND A PROCESS FOR THEIR MANUFACTURE AND THEIR USE
Abstract of the Disclosure:
Synthetic alkylesters of phospholipid acid, the structu-ral analogues thereof, their physiologically acceptable salts as well as a process for preparing them and their use.
Description
HOE 74/B 036 ~ ~
~63:131 The present invention relates to synthetic alkyl esters of phospholipid acid, the structural analogs and the physiologi-cally acceptable salts thereof and to a process for their manu-facture.
The process of the invention comprises A) reacting a primary alcohol of the formula wherein R3 stands for a saturated or unsaturated straight-chain or branched alkyl group of one to 25 carbon atoms, which may be substituted by halogen, a cycloalkyl group or an aromatic group, with phosphorus oxychloride in the presence of an inert organic solvent, and B) reacting the resulting phosphorylation agent oE the ormula Cl \
wherein R3 is defined as above, with a polyhydroxy compound hauing a free hydroxy group and the further hydroxy groups of which are protected.
The process of the present invention permits the preparation of large numbers of alkyl esters of phospholipid acid by simply reacting a primary alcohol with phosphorus oxychloride. The resulting phosphorylation agent of formula II may be reacted directly without isolation with the polyhydroxy compound without having to distil the phosphorylation agent.
In the above formula I, R3 may stand for a saturated or un-saturated straight-chain or branched alkyl group having 1 to 25 carbon atoms, for example 1 to 23, 1 to 21, 1 to 18, 1 to 16, 3 to 25, 3 to 23, 3 to 21, 3 to 18, 3 to 16, 3 to 14, 3 to 12, .~ - 2 - ~
: . . .. ,. :: .. . ., : ,, ,,, ,, ............... : .. : -.~
. . ~ . ::. , . : : ~ .: .
~063131 liOE 74/~ 036 3 to 10, 4 to 25, 4 to 21, 4 to 18, 4 to 1~, 4 to 12, 6 to 25, 6 to 18 or 6 to 14 carbon atoms.
The group represented by R3 may contain one or more double bonds or triple bonds and may be substituted by halogen, such as bromine, chlorine, iodine or fluorine. It may also be substituted by one or more cycloalkyl groups having 4 to 8, preferably 5 to 7, carbon atoms, or by 1 or more aromatic groups, such as phenyl or naphthyl groups or substituted phenyl groups. The reaction of the primary alcohol with the phosphorus oxychloride yields the phosphorylation agent of the general formula II.
The reaction of the primary alcohol with phosphorus oxy-chloride is carried out in the presence of an inert organic sol-vent, for example halogenated hydrocarbons, such as chloroform or carbon tetrachloride. The reaction is carried out without adding a base. The molar ratio of alcohol to phosphorus oxy chloride is generally 1:2, but it may of course b~ varied within ;
certain limits. For example, 1 mol of alcohol may be reacted with ;~
1.7 to 2.3 mols of phosphorus oxychloride. The reaction is generally carried out under anhydrous conditions. The reaction temperature is generally room temperature but temperatures of -10 to ~80C, for example from 20C to ~0C, may also be applied.
The reaction time depends on the temperature chosen and ranges from half an hour to 15 hours generally from 10 to 12 hourst when room temperature is applied. ~
When the reaction which can be controlled by thin-layer ;;
chromatography is complete excess phosphorus oxychloride and excess hydrochloric acid may be eliminated in a hydrogen vacuum, for example at 30 to 35C. The alkyl phosphoric aci~ dichloride remains as a residue. This alkyl phosphoric acid dichloxide may --~63~3~ HOE 74/B 036 directly be used for the phosphorylation reaction without further purification. A distillation is not necessary. Compared to known phosphorylation methods, this is a substantial advantage since many alkyl phosphoric acid dichlorides tend to decompose in an explosive manner.
The phosphorylation agent of the general formula II is very reactive and reacts with a large number of polyhydroxy compounds containing a free hydroxy group. The reaction is preferably carried out with exclusion of moisture in an inert organic solvent, for example a chlorinated hydrocarbon, such as chloroform or carbon tetrachloride. Other organic solvents, such as toluene or xylene or benzene may also be used; absolute solvents are however pre-ferred.
The reaction of the phosphorylation agent with the poly-hydroxy compound may be carried out within a wide range of -temperature, for example from -10C to +50C, preferably at room temperature. The reaction time used depends on the reaction tem-perature chosen, it ranges generally from half an hour to 5 or 6 hours. The phosphorylation reaction is preferably carried out in the presence of a base, for example of triethyl amine.
The phosphorylation agent obtained according to this in-vention allows a number of alkyl esters of phospholipid acid to be obtained. As polyhydroxy compounds, any polyhydroxy compounds may be used which contain a free hydroxy group and the other hydroxy groups of which are protected, for example by esteri-fication, e~herification, acetal- or ketal formation. In general, the polyhydroxy compound used is a glyceride or a correspondingly higher homolog. It is thus possible according to the invention to phosphorylate erythritol, pentitol or hexitol derivatives but .. .. .. . . .
;: , . : . : . :
,. . . , ' ! ' -' : ' ';
~63131 flOE 74/B 036 also cyclic polyhydroxy compounds, such for example as cyclic saccharic alcohols. Generally, monosaccaride derivatives and oligo-saccharide derivatives may be ùsed according to the process of the invention.
The process of the present invention may be carried out us-ing racemic mixtures of pure optical isomers. The present invention also provides the products obtained according to the process of this invention. As already mentioned above, this process yields a large variety of different alkyl esters of phospholipid acid, of which individual groups are hereinafter cited as example that can be prepared according to the process of the invention.
1. Alkyl esters of phospholipid acid Hl- o-cO-R~ III
OH ;~
H C - O - CO - R
¦ OH
~2C - O - CO - R2 In the formulae III and IV, R3 is defined as above. Rl and R2 each stand for a saturated or unsaturated straight-chain or branched alkyl group having 5 to 25, 5 to 21 or 5 to 18, 5 to 16 carbon atoms, which may also be substituted by 1 or more, i.e~
~63:131 The present invention relates to synthetic alkyl esters of phospholipid acid, the structural analogs and the physiologi-cally acceptable salts thereof and to a process for their manu-facture.
The process of the invention comprises A) reacting a primary alcohol of the formula wherein R3 stands for a saturated or unsaturated straight-chain or branched alkyl group of one to 25 carbon atoms, which may be substituted by halogen, a cycloalkyl group or an aromatic group, with phosphorus oxychloride in the presence of an inert organic solvent, and B) reacting the resulting phosphorylation agent oE the ormula Cl \
wherein R3 is defined as above, with a polyhydroxy compound hauing a free hydroxy group and the further hydroxy groups of which are protected.
The process of the present invention permits the preparation of large numbers of alkyl esters of phospholipid acid by simply reacting a primary alcohol with phosphorus oxychloride. The resulting phosphorylation agent of formula II may be reacted directly without isolation with the polyhydroxy compound without having to distil the phosphorylation agent.
In the above formula I, R3 may stand for a saturated or un-saturated straight-chain or branched alkyl group having 1 to 25 carbon atoms, for example 1 to 23, 1 to 21, 1 to 18, 1 to 16, 3 to 25, 3 to 23, 3 to 21, 3 to 18, 3 to 16, 3 to 14, 3 to 12, .~ - 2 - ~
: . . .. ,. :: .. . ., : ,, ,,, ,, ............... : .. : -.~
. . ~ . ::. , . : : ~ .: .
~063131 liOE 74/~ 036 3 to 10, 4 to 25, 4 to 21, 4 to 18, 4 to 1~, 4 to 12, 6 to 25, 6 to 18 or 6 to 14 carbon atoms.
The group represented by R3 may contain one or more double bonds or triple bonds and may be substituted by halogen, such as bromine, chlorine, iodine or fluorine. It may also be substituted by one or more cycloalkyl groups having 4 to 8, preferably 5 to 7, carbon atoms, or by 1 or more aromatic groups, such as phenyl or naphthyl groups or substituted phenyl groups. The reaction of the primary alcohol with the phosphorus oxychloride yields the phosphorylation agent of the general formula II.
The reaction of the primary alcohol with phosphorus oxy-chloride is carried out in the presence of an inert organic sol-vent, for example halogenated hydrocarbons, such as chloroform or carbon tetrachloride. The reaction is carried out without adding a base. The molar ratio of alcohol to phosphorus oxy chloride is generally 1:2, but it may of course b~ varied within ;
certain limits. For example, 1 mol of alcohol may be reacted with ;~
1.7 to 2.3 mols of phosphorus oxychloride. The reaction is generally carried out under anhydrous conditions. The reaction temperature is generally room temperature but temperatures of -10 to ~80C, for example from 20C to ~0C, may also be applied.
The reaction time depends on the temperature chosen and ranges from half an hour to 15 hours generally from 10 to 12 hourst when room temperature is applied. ~
When the reaction which can be controlled by thin-layer ;;
chromatography is complete excess phosphorus oxychloride and excess hydrochloric acid may be eliminated in a hydrogen vacuum, for example at 30 to 35C. The alkyl phosphoric aci~ dichloride remains as a residue. This alkyl phosphoric acid dichloxide may --~63~3~ HOE 74/B 036 directly be used for the phosphorylation reaction without further purification. A distillation is not necessary. Compared to known phosphorylation methods, this is a substantial advantage since many alkyl phosphoric acid dichlorides tend to decompose in an explosive manner.
The phosphorylation agent of the general formula II is very reactive and reacts with a large number of polyhydroxy compounds containing a free hydroxy group. The reaction is preferably carried out with exclusion of moisture in an inert organic solvent, for example a chlorinated hydrocarbon, such as chloroform or carbon tetrachloride. Other organic solvents, such as toluene or xylene or benzene may also be used; absolute solvents are however pre-ferred.
The reaction of the phosphorylation agent with the poly-hydroxy compound may be carried out within a wide range of -temperature, for example from -10C to +50C, preferably at room temperature. The reaction time used depends on the reaction tem-perature chosen, it ranges generally from half an hour to 5 or 6 hours. The phosphorylation reaction is preferably carried out in the presence of a base, for example of triethyl amine.
The phosphorylation agent obtained according to this in-vention allows a number of alkyl esters of phospholipid acid to be obtained. As polyhydroxy compounds, any polyhydroxy compounds may be used which contain a free hydroxy group and the other hydroxy groups of which are protected, for example by esteri-fication, e~herification, acetal- or ketal formation. In general, the polyhydroxy compound used is a glyceride or a correspondingly higher homolog. It is thus possible according to the invention to phosphorylate erythritol, pentitol or hexitol derivatives but .. .. .. . . .
;: , . : . : . :
,. . . , ' ! ' -' : ' ';
~63131 flOE 74/B 036 also cyclic polyhydroxy compounds, such for example as cyclic saccharic alcohols. Generally, monosaccaride derivatives and oligo-saccharide derivatives may be ùsed according to the process of the invention.
The process of the present invention may be carried out us-ing racemic mixtures of pure optical isomers. The present invention also provides the products obtained according to the process of this invention. As already mentioned above, this process yields a large variety of different alkyl esters of phospholipid acid, of which individual groups are hereinafter cited as example that can be prepared according to the process of the invention.
1. Alkyl esters of phospholipid acid Hl- o-cO-R~ III
OH ;~
H C - O - CO - R
¦ OH
~2C - O - CO - R2 In the formulae III and IV, R3 is defined as above. Rl and R2 each stand for a saturated or unsaturated straight-chain or branched alkyl group having 5 to 25, 5 to 21 or 5 to 18, 5 to 16 carbon atoms, which may also be substituted by 1 or more, i.e~
2, 3, 4 and more halogen atoms, such as fluorine, chlorine, bromine or iodine atoms. The alkyl groups may also be substituted by a cycloalkyl group or an aromatic ring. If the alkyl groups are substituted by a cycloalkyl group, this may contain 4 to 8, pre-ferably 5, 6 or 7, carbon atoms. I~ the alkyl groups are sub-,. ~ , .
- . . , - ., , ~ : . .
~OE 7~/B 036 ~63~31 stituted by an aromatic ring, this may for example be a phenyl ring ox a naphthyl ring which may also carry further substituents.
Starting substances are racemic or optically active 1,2- or 1,3-diglycerides having saturated, unsaturated, branched or halo-genated fatty acids or fatty acids which contain a cycloalkane or aromatic ring.
2. Lyso compounds of compounds of Group 1 Starting compounds are l-acyl-2-benzyl glycerols or l-benzyl-2-acyl glycerols. The phosphorylation reaction provides the lyso compounds by catalytic debenzylation. Unsaturated compounds are prepared with the help of protective groups which may be eliminated by a mild acid hydrolysis.
The starting compounds may also be obtained by biochemical methods from the compounds of Group 1 by enzymatic splitting with the phospholipases Al and A2.
- . . , - ., , ~ : . .
~OE 7~/B 036 ~63~31 stituted by an aromatic ring, this may for example be a phenyl ring ox a naphthyl ring which may also carry further substituents.
Starting substances are racemic or optically active 1,2- or 1,3-diglycerides having saturated, unsaturated, branched or halo-genated fatty acids or fatty acids which contain a cycloalkane or aromatic ring.
2. Lyso compounds of compounds of Group 1 Starting compounds are l-acyl-2-benzyl glycerols or l-benzyl-2-acyl glycerols. The phosphorylation reaction provides the lyso compounds by catalytic debenzylation. Unsaturated compounds are prepared with the help of protective groups which may be eliminated by a mild acid hydrolysis.
The starting compounds may also be obtained by biochemical methods from the compounds of Group 1 by enzymatic splitting with the phospholipases Al and A2.
3. Analogs with saccharic alcohols (HC - O - CO ~ R)x V
H2C ~
In the above formula V, R3 is defined as above, and R has the same meaning as Rl and R2, and X stands for zero or an integer of from 1 to 5, i.e. 0, 1, 2, 3, 4 or 5.
Starting substances are acylated saccharic alcohols which contain a free hydroxy group.
H2C ~
In the above formula V, R3 is defined as above, and R has the same meaning as Rl and R2, and X stands for zero or an integer of from 1 to 5, i.e. 0, 1, 2, 3, 4 or 5.
Starting substances are acylated saccharic alcohols which contain a free hydroxy group.
4. ~ther analogs of the compounds of Groups 1 to 3 and ether/
ester analogs of the groups of compounds 1 and 3, for example ,, ~.,:,...
..
.
1063131 HOE 74/B 036 ~ ~
H2C -- O - Rl . ~
H2C - O - PO - o - R
OH
H2l Rl HC - O - PO - O ~ R3 VII
I OH
H2C~ ~ ~
In the formulae VI and VII, Rl, R2 and R3 are defined as above.
Starting substances are 1,2- and 1,3-dialkylglycerol ethers or acylglycerol alkyl ethers. The alkyl radicals may be saturated, un~aturated, branched or halogenated and may also contain a cyclo-alkane or an aromatic ring.
ester analogs of the groups of compounds 1 and 3, for example ,, ~.,:,...
..
.
1063131 HOE 74/B 036 ~ ~
H2C -- O - Rl . ~
H2C - O - PO - o - R
OH
H2l Rl HC - O - PO - O ~ R3 VII
I OH
H2C~ ~ ~
In the formulae VI and VII, Rl, R2 and R3 are defined as above.
Starting substances are 1,2- and 1,3-dialkylglycerol ethers or acylglycerol alkyl ethers. The alkyl radicals may be saturated, un~aturated, branched or halogenated and may also contain a cyclo-alkane or an aromatic ring.
5. Dialkyl ketone glycerol_phosphoric acid alkyl esters \C / ~ ~
HC - O \ R2 VIII
OH -H2C - o \
¦ C \ IX
HC - O H
.., . :~
OH ~ -In the above formulae VIII and IX7 Rl, R2 and R3 are defined as above.
Starting substances are the 1,2- and 1,3-dialkyl ketone ~-glycerols or the corresponding acetals which may be obtained from `' - 7 -~063~31 HOE 74/B 036 glycerol or 2-benzyl glycerol by reaction with the corresponding ketones or aldehydes. The ketones or aldehydes may be saturated, unsaturated, branched or halogenated and ~lay also contain a cycloalkane or an aromatic ring.
HC - O \ R2 VIII
OH -H2C - o \
¦ C \ IX
HC - O H
.., . :~
OH ~ -In the above formulae VIII and IX7 Rl, R2 and R3 are defined as above.
Starting substances are the 1,2- and 1,3-dialkyl ketone ~-glycerols or the corresponding acetals which may be obtained from `' - 7 -~063~31 HOE 74/B 036 glycerol or 2-benzyl glycerol by reaction with the corresponding ketones or aldehydes. The ketones or aldehydes may be saturated, unsaturated, branched or halogenated and ~lay also contain a cycloalkane or an aromatic ring.
6. Cycloalkyl ketone glycerol phosphoric acid alkyl esters H C - O
2 \
/C (CH2)y X
HC - O
H2C - O - PO - o - R3 OH
H C - O
2 \ ~,_-----__~
/ (CH2)y XI
HC - O ~
OH
In the above formulae, R3 is defined as above, and y stands for an integer of from 5 to 32, for example 5 to 28, 5 to 24, 5 to 18, 5 to 16, 5 to 14, 5 to 12, 5 to 10, 5 to 8.
Starting substances are 1,2- and 1,3-cycloalkyl ketone glycerols which may be obtained from glycerol or 2-benzylglycerol by reaction with the corresponding cycloalkanone.
2 \
/C (CH2)y X
HC - O
H2C - O - PO - o - R3 OH
H C - O
2 \ ~,_-----__~
/ (CH2)y XI
HC - O ~
OH
In the above formulae, R3 is defined as above, and y stands for an integer of from 5 to 32, for example 5 to 28, 5 to 24, 5 to 18, 5 to 16, 5 to 14, 5 to 12, 5 to 10, 5 to 8.
Starting substances are 1,2- and 1,3-cycloalkyl ketone glycerols which may be obtained from glycerol or 2-benzylglycerol by reaction with the corresponding cycloalkanone.
7. Alkyl esters of desoxylyso phospholipid acid HzC - O - CO - R
(I 2~m XII
H2C - O - IO - o - R3 OH
, ' :
, .
(I 2~m XII
H2C - O - IO - o - R3 OH
, ' :
, .
- 8 -, .~ .
. . :. ~ , , , . . ~ , . ;
-:
. .
: ~ ~ : . ::: .
31 ;
( 2)m ;~
¦ XIII
HC - O - CO - R
OH
( CH2 ) p ' :.
HC - O - CO ~ Rl XIV ~
(fH2) q ~: .
10 H2C - O - lo - o - R3 OH
In the above formulae, Rl and R3 are defined as above, and m stands for zero or for an integer of rom 1 to 14, for example for 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, and p ~ ~ = m.
15 As starting substances, the monoacylalkane diols are preferred. ~
The alkane diols may be saturated, unsaturated, branched or ~ ;
halogenated and may also contain a cycloalkane or an aromatic ~
ring. ~ ~ ;
8. Ether analogs of compounds of Group 6 Methods for the preparation of the said starting substances are known (s. publication of A.J. Slotboom and P.P.N.
Bonsen "Chem. Phys. Liquids" (1970), pages 301 to 398).
The compounds of the invention corresponding to formulae I, III to VI have valuable pharmacological properties and they are potent surfactants which, owing to their structural analogy with the phospholipids present in the cell membranes, are able to influence the surface activity of these membranes. Their negative charge a~ physiological p~-values is moreover capable of influencing the charge of biological membranes.
_ g _ ,.
,~ .
: , ~- : -: .:: : . . . . .. ., . :: : , . . .
1063~3~ HOE 74/B 036 ~
Owing to these properties, these substances can be expected to modify the activity of pharmaceuticals by increasing their ahsorbability and their distribution in the organism~ The compounds are valuable additives in the manufacture of drugs.
The compounds of formulae I and III to IV are readily dis-persible in water and give emulsions which are stable over a wide pH range. It is surprising that these emulsions are even still stable at a pH of 1.0 whilst, for example, emulsions of lecithin precipitate in flakes already at a pH of 2Ø
Dispersions of the said compounds are also suitable to pass unchanged through the stomach (pH 1.5) and to improve, for example, the absorbability of fats.
The compounds of formulae II, VII and VIII are potent surfactants and have a lytic activity on natural membranes (for example erythrocytes). They may therefore be used in many ways for the disintegration of these membranes or, when applied in sub-lytic dosages, for a modification of the properties of membranes, which again may influence the activity of pharma- ~
ceutical compositions. `
The compounds of the invention generally have very good emulsifying properties. Having a structure similar to that of natural products, they are physiologically acceptable . . ~, . . , ; . . , . :
. : ........ ' ' . :: ', - . ~ , , . : . , ,. : ~ , , -: , . , ~::
., : :.
., . . . . , . . - , 1~63131 HOE 74/B 03Ç
in foodstuffs and may therefore be used for a variety of applications. ~hen added to margarine, they bring about a better linkage to water, thus preventing it from splashing in the frying pan and imparting to it butter like properties when used for frying. They may be used in sweets for emulsifying sirup with fat and also prevent: the fat getting -~`
rank. When applied for cosmetic purposes and for the making of soaps small additives of the products of the invention improve the suppleness and absorption of ointments, creams, tooth pastes, soaps and the like.
The following examples illustrate the invention.
Example 1 General preparation of alkylphosphoric acid dichlorides:
80 g (0,6 mol) of POC13 (freshly distilled, boiling point ~-105 to 107C) in 100 ml of absolute chloroform (distilled for 90 minutes with circulation over P2O5) were placed in a three-neck flask equipped with cooler, dropping funnel and nitrogen inlet tube. While stirring by means of a magnetically operated stirrer, nitrogen was slowly fed in, and 0.3 mol of the said alcohol in 50 ml of absolute chloro- ~ -form was added dropwise. The mixture was stirred for 12 hours ; ~
~ ' -- 1 1 -- , .. ...
~06313~ HOE 74/B 036 at room temperature, and the resulting hydrogen chloride, excess POC13 and chloroform were eliminated at 30C in the rotary evaporator. To eliminate any trace of POC13, 50 ml of toluene were added and likewise drained off. ~;
The remaining oily substance, i.e. the alkyl-phosphoric acid dichloride, can be reacted further without purification.
Distillation was performed on some of low boiling alkyl phosphoric acid dichlorides and the following boiling points were observed: boiling point at 10 mm Hg CH3-O-PO-C12 44 to 47C
C2H5-O-Po C12 54 to 56C
C3H7-O-PO C12 66 to 68C
C H -O-PO-C12 85 to 87C
. .
The reaction provided a yield of 90 to 100~ and can be ~
controlled by thin-layer chromatography. ~ ;`
. ,~
Example 2 .
Preparation of ~-bromoalkyl-phosphoric acid dichlorides:
a) Preparation of bromo alcohols having different chain length according to a simple process:
Compounds of formula Br - (CH2)n - OH
in which n stands for the integer of 4 to 10, were synthesized. ;;
:
. ~ .
.. , . . . . . ~ ` . . .. .,, ,,, ,, ,, : : : . .. . . .
HOE 74/~ 036 ~063~3~ - -The starting products were diol of corresponding chain length having terminal alcohol functions. Since only one ~;~
bromine atom per diol molecule was to be introduced, a method had to be chosen wherein the reaction product was immediately eliminated from the proper reaction medium and ~; ;
thus further reaction was excluded. For this purpose the extraction method was suitable.
In a round flask the diol and hydrobromic acid were placed.
The starting products were overlaid with petroleum benzine or with benzene/petroleum benzine. The selection of the extraction agent depended on the insolubility of the diol and on the good solubility of the reaction products therein.
The round flask was equipped with a reflux condenser. While energetically stirring by means o a magnetically operated stirrer, the mixture was then refluxed by means of an adequate heating device until the starting product had completely reacted. The proceeding reaction was checked by means of ~-thin-layer chromatograms.
Subsequently the extraction medium phase was separated and dried with calcium sulfate. After the siccative had been filtered off the extraction medium was eliminated in the rotary evaporator. The residue was subjected to a fractionated distillation in an oil pump vacuum.
:
-- , : . . .
.. , . . . .: :.
:: : -: : ~,, : :. ;.:: :: . ., :;
1~63131 HOE 74/B 036 The yields were about 80 to 95% o~ the theoretical yield, calculated on the diol used.
4-~romobutanol-(1) and 5-bromopentanol-(1) were prepared as follows: ~;
0,25 mol = 22,5 g of 1,4-butanediol or 26 g o~ 1,5-pentane-diol, 0,48 mol = 80 g of HBr(47~, 500 ml of benzene and 50 ml of petroleumbenzine, boiling point 100 to 140C, were refluxed for 6,5 and 6 hours, respectively.
The rest of the brominated alcohols was prepared as ~ollows~
0,25 mol = 29,6 g of 1,6-hexanediol or the corresponding diol, 0,48 mol = 80 g of HBr(47%), 1500 ml of petroleum benzine, boiling point 100 to 140C, were refluxed.
Reaction product Reaction time physical constants 4-bromobutanol-(1) 6,5 hr b.p.(0.7 mm Hg) 58 to 60C5-bromopentanol-~1) 6 hr b.p.(0.5 mm Hg) 72 to 74C6-bromohexanol-tl) 1,5 hr b.p.(0.6 mm Hg) 85 to 87C7-bromoheptanol-~1) 1,5 hr b.p.(0.5 mm Hg) 87 to 89C8-bromooctanol-(1) 1 hr b.p.~0.5 mm Hg) 110 to 112C
. . :. ~ , , , . . ~ , . ;
-:
. .
: ~ ~ : . ::: .
31 ;
( 2)m ;~
¦ XIII
HC - O - CO - R
OH
( CH2 ) p ' :.
HC - O - CO ~ Rl XIV ~
(fH2) q ~: .
10 H2C - O - lo - o - R3 OH
In the above formulae, Rl and R3 are defined as above, and m stands for zero or for an integer of rom 1 to 14, for example for 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, and p ~ ~ = m.
15 As starting substances, the monoacylalkane diols are preferred. ~
The alkane diols may be saturated, unsaturated, branched or ~ ;
halogenated and may also contain a cycloalkane or an aromatic ~
ring. ~ ~ ;
8. Ether analogs of compounds of Group 6 Methods for the preparation of the said starting substances are known (s. publication of A.J. Slotboom and P.P.N.
Bonsen "Chem. Phys. Liquids" (1970), pages 301 to 398).
The compounds of the invention corresponding to formulae I, III to VI have valuable pharmacological properties and they are potent surfactants which, owing to their structural analogy with the phospholipids present in the cell membranes, are able to influence the surface activity of these membranes. Their negative charge a~ physiological p~-values is moreover capable of influencing the charge of biological membranes.
_ g _ ,.
,~ .
: , ~- : -: .:: : . . . . .. ., . :: : , . . .
1063~3~ HOE 74/B 036 ~
Owing to these properties, these substances can be expected to modify the activity of pharmaceuticals by increasing their ahsorbability and their distribution in the organism~ The compounds are valuable additives in the manufacture of drugs.
The compounds of formulae I and III to IV are readily dis-persible in water and give emulsions which are stable over a wide pH range. It is surprising that these emulsions are even still stable at a pH of 1.0 whilst, for example, emulsions of lecithin precipitate in flakes already at a pH of 2Ø
Dispersions of the said compounds are also suitable to pass unchanged through the stomach (pH 1.5) and to improve, for example, the absorbability of fats.
The compounds of formulae II, VII and VIII are potent surfactants and have a lytic activity on natural membranes (for example erythrocytes). They may therefore be used in many ways for the disintegration of these membranes or, when applied in sub-lytic dosages, for a modification of the properties of membranes, which again may influence the activity of pharma- ~
ceutical compositions. `
The compounds of the invention generally have very good emulsifying properties. Having a structure similar to that of natural products, they are physiologically acceptable . . ~, . . , ; . . , . :
. : ........ ' ' . :: ', - . ~ , , . : . , ,. : ~ , , -: , . , ~::
., : :.
., . . . . , . . - , 1~63131 HOE 74/B 03Ç
in foodstuffs and may therefore be used for a variety of applications. ~hen added to margarine, they bring about a better linkage to water, thus preventing it from splashing in the frying pan and imparting to it butter like properties when used for frying. They may be used in sweets for emulsifying sirup with fat and also prevent: the fat getting -~`
rank. When applied for cosmetic purposes and for the making of soaps small additives of the products of the invention improve the suppleness and absorption of ointments, creams, tooth pastes, soaps and the like.
The following examples illustrate the invention.
Example 1 General preparation of alkylphosphoric acid dichlorides:
80 g (0,6 mol) of POC13 (freshly distilled, boiling point ~-105 to 107C) in 100 ml of absolute chloroform (distilled for 90 minutes with circulation over P2O5) were placed in a three-neck flask equipped with cooler, dropping funnel and nitrogen inlet tube. While stirring by means of a magnetically operated stirrer, nitrogen was slowly fed in, and 0.3 mol of the said alcohol in 50 ml of absolute chloro- ~ -form was added dropwise. The mixture was stirred for 12 hours ; ~
~ ' -- 1 1 -- , .. ...
~06313~ HOE 74/B 036 at room temperature, and the resulting hydrogen chloride, excess POC13 and chloroform were eliminated at 30C in the rotary evaporator. To eliminate any trace of POC13, 50 ml of toluene were added and likewise drained off. ~;
The remaining oily substance, i.e. the alkyl-phosphoric acid dichloride, can be reacted further without purification.
Distillation was performed on some of low boiling alkyl phosphoric acid dichlorides and the following boiling points were observed: boiling point at 10 mm Hg CH3-O-PO-C12 44 to 47C
C2H5-O-Po C12 54 to 56C
C3H7-O-PO C12 66 to 68C
C H -O-PO-C12 85 to 87C
. .
The reaction provided a yield of 90 to 100~ and can be ~
controlled by thin-layer chromatography. ~ ;`
. ,~
Example 2 .
Preparation of ~-bromoalkyl-phosphoric acid dichlorides:
a) Preparation of bromo alcohols having different chain length according to a simple process:
Compounds of formula Br - (CH2)n - OH
in which n stands for the integer of 4 to 10, were synthesized. ;;
:
. ~ .
.. , . . . . . ~ ` . . .. .,, ,,, ,, ,, : : : . .. . . .
HOE 74/~ 036 ~063~3~ - -The starting products were diol of corresponding chain length having terminal alcohol functions. Since only one ~;~
bromine atom per diol molecule was to be introduced, a method had to be chosen wherein the reaction product was immediately eliminated from the proper reaction medium and ~; ;
thus further reaction was excluded. For this purpose the extraction method was suitable.
In a round flask the diol and hydrobromic acid were placed.
The starting products were overlaid with petroleum benzine or with benzene/petroleum benzine. The selection of the extraction agent depended on the insolubility of the diol and on the good solubility of the reaction products therein.
The round flask was equipped with a reflux condenser. While energetically stirring by means o a magnetically operated stirrer, the mixture was then refluxed by means of an adequate heating device until the starting product had completely reacted. The proceeding reaction was checked by means of ~-thin-layer chromatograms.
Subsequently the extraction medium phase was separated and dried with calcium sulfate. After the siccative had been filtered off the extraction medium was eliminated in the rotary evaporator. The residue was subjected to a fractionated distillation in an oil pump vacuum.
:
-- , : . . .
.. , . . . .: :.
:: : -: : ~,, : :. ;.:: :: . ., :;
1~63131 HOE 74/B 036 The yields were about 80 to 95% o~ the theoretical yield, calculated on the diol used.
4-~romobutanol-(1) and 5-bromopentanol-(1) were prepared as follows: ~;
0,25 mol = 22,5 g of 1,4-butanediol or 26 g o~ 1,5-pentane-diol, 0,48 mol = 80 g of HBr(47~, 500 ml of benzene and 50 ml of petroleumbenzine, boiling point 100 to 140C, were refluxed for 6,5 and 6 hours, respectively.
The rest of the brominated alcohols was prepared as ~ollows~
0,25 mol = 29,6 g of 1,6-hexanediol or the corresponding diol, 0,48 mol = 80 g of HBr(47%), 1500 ml of petroleum benzine, boiling point 100 to 140C, were refluxed.
Reaction product Reaction time physical constants 4-bromobutanol-(1) 6,5 hr b.p.(0.7 mm Hg) 58 to 60C5-bromopentanol-~1) 6 hr b.p.(0.5 mm Hg) 72 to 74C6-bromohexanol-tl) 1,5 hr b.p.(0.6 mm Hg) 85 to 87C7-bromoheptanol-~1) 1,5 hr b.p.(0.5 mm Hg) 87 to 89C8-bromooctanol-(1) 1 hr b.p.~0.5 mm Hg) 110 to 112C
9-bromononanol-(1) 1 hr b.p.(0.4 mm Hg) 112 to 114C
10-bromodecanol-(1) 30 min b.p.(0.3 mm Hg) 124 to 126C ~-.
-. ,, ., .:, ,. ; .:.- : , , .. : .: . :. . . ,:: .. , :. : ... . :: . .: . :-: :. :i .. : :.
- : :~ : : . .:
-~3~3~ HOE 74/B 036 Including 8-bromooctanol-(1) the reaction products were -colourless liquids. 9-Bromononanol(l) and 10-bromodecanol~
are white and solid products at room temperature. Brominated alcohols of greater chain length may principally be prepared according to the same process. Since these reaction products are all solid products, they are purified by recrystallization.
(b) Preparation of ~ -bromoalkylphosporic acid dichloride:
32 mmol = 30 ml of phosphorus oxytrichloride (freshly distilled, boiling point 105 to 107C) in 70 ml of absolute chloroform tdistilled for 90 minutes with circulation over P205) were placed in a round flask. At room temperature, nitrogen i was introduced into the solution for a short time to expel air.
The flask was equipped with a dropping funnel and sealed air-tight. While stirring by means of a magnetically operated stirrer, 20 mmol of the brominated alcohol of desired chain length in 50 ml of absolute chloroform were added dropwise slowly at room temperature with the exclusion of moisture.
Stirring was continued for about 12 hours. The hydrogen chloride resulting from the reaction as well as excess phosphorus oxytrichloride and chloroform were eliminated at 30C in the rotary evaporator. To eliminate every trace of phosphorus oxytrichloride toluene was added and likewise drained off.
: , : . :: - ~ - ~ :. . :
~:
: : .. , , 1063~31 HOE 74/B 036 The yield was 95 to 100~ and the conversion reaction can be checked by thin-layer chromatography.
Example 3 General preparation of alkylesters of phospholipid acid and of structural analogues thereof:
The phosporylation agent prepared in Example 1 or 2 (0.3 mol~ was dissolved in 100 ml of absolute chloroform (distilled for 90 minutes with circulation over P2O5), and the solution was cooled to 0 to 5C in an ice bath. While stirring by means o a magnetically operated stirrer, 60 g (0.6 mol) of absolute triethylamine tdried over lithiumaluminumhydrlde and freshly distilled) were added dropwise to 50 ml of absolute chloroform. The ice bath was then replaced by a water bath of 20C. While steadily stirring, a solution of the corresponding starting substance (0,15 mol) in 150 ml of absolute chloro-form was added dropwise to the phosporylation mixture.
Checking by means of thin-layer chromatography made sure that the reaction was almost complete already after the drop-wise addition. After another 6 hours at 40C the reaction mixture was freed in the rotary evaporator at 35C from solvent, and the residue was taken up in 450 ml of tetrahydro-furan. While stirring, 1 M sodium acetate solution of pH 8.4 ~ -,. .
. , . . .'. , ' :
' . , ' , , . . ' : ~' , ~0~3~3~ HOE 74/B 036 was added to the suspension or solution of the reaction ;
mixture in tetrahydrofuran until the water phase remained neutral (pH about 7). For this purpose, about 450 ml of lM sodium acetate solution had to be added. The hydrolysed reaction product was extracted as the sodium salt by means of 450 ml of diisopropylether. The water phase was again extracted by means of 200 ml of diisopropylether. The combined diisopropylether extracts were mixed while stirring with 10 g of sodium carbonate to eliminate water and to assure a `
complete conversion of the reaction product into the sodium salt.
For the preparation of derivatives having less than a total o 14 carbon atoms, the reaction solution was acidified with HCl (pH about 2) prior to the extraction with diisopropyl ether. Derivatives having a very short chain were better extxacted as the free acids and can be crystallized by care-fully adding sodium methylate in methanol.
The diisopropylether phase was filtered and the filtrate was evaporated in vacuo. The residue was recrystallized from ethylmethylketone/acetone mixtures~ Generally the resulting reaction products are analytically pure. Otherwise a complete purification of the products is brought about by chromato-graphy on silica gel. The yields of analytically pure product ~ -~
vary between 70 and 90% (calculated on the starting products ', ,' ' .: : . , :- : , . .
: , . , .. . . .
:: . ' , ' ~ . . . ' , :
1063~31 HOE 74/B 036 used).
The following compounds were prepared:
Compound of Group 1:
sn-1,2-dimyristoylglycerol-3-phosphoric acid methyl ester, as ' 32 62 8 (628.8) calculated: C 61.12% H9.94~ P 4.93%.
The data found complied with the calculated values.
Compound of Group 2:
sn-l-myristoylglycerol-3~phosphoric acid methyl ester, as sodium salt, C18H36NaO7P (418.5) calculated: C 51.67~ H 8.67% P 7.40%.
The data found complied with the calculated values.
Compound of Group 3:
1/2,3,4,5-pentapalmitoyl-D-mannitol-6-phosporic acid butyl ester, as sodium salt, C90Hl72NaOl4P (1532.3) calculated: C 70.55% H 11.32~ P 2.02%.
The data found complied with the calculated values.
Compound of Group 4:
/ Glyceroldioctyl etherphosphoric acid-(3)-~-bromoethyl ester, as sodium salt, C21H43BrNaO6P t525.5) calculated: C 48.00% H 8.25% Br 15,21% P 5.90%.
The data found complied with the calculated values.
Compound cf Group 5:
Diheptadecyl ketone glycerol-3-phosphoric acid octyl ester, as sodium salt, C46H92NaO6P (795.21) calculated: C 69.48% H 11.66% P 3.90%.
The data found complied with the calculated values.
Compound of Group 6:
Cyclopentadecyle ketone glycerol-3-phophoric acid-B-bromoethylester, , : . , . ,, ,~ . .:
::
- , . ~ , .
1~63~31 as sodium salt, C20H37BrNap (484-4) calculated: C 49,59~ H 7,70% Br 16,49~ P 6,39%.
The data found complied with the calculated values.
Compound of Group 7:
Oleoylhexanediol-(1,6)-phosphoric acid isopropyl ester, as sodium salt, C27H52NaO6P (526.68) calculated: C 61.57% H 9.52% P 5.88%.
The data found complied with the calculated values.
Compound of Group 8:
Propanediol-(1,3)-hexadecyl ether phosphoric acid hexyl ester, as sodium salt, C25H52NaO5P (486.7) calculated: C 61,70% EI 10,77% P 6,37%.
The data Eound complied with the calculated values.
, . -- 1 9 -- . .
_. .
, , " , .. . . . ~ . ,, :. , , - . : ,, , :
. . , . . , . , . . : . -.
-. ,, ., .:, ,. ; .:.- : , , .. : .: . :. . . ,:: .. , :. : ... . :: . .: . :-: :. :i .. : :.
- : :~ : : . .:
-~3~3~ HOE 74/B 036 Including 8-bromooctanol-(1) the reaction products were -colourless liquids. 9-Bromononanol(l) and 10-bromodecanol~
are white and solid products at room temperature. Brominated alcohols of greater chain length may principally be prepared according to the same process. Since these reaction products are all solid products, they are purified by recrystallization.
(b) Preparation of ~ -bromoalkylphosporic acid dichloride:
32 mmol = 30 ml of phosphorus oxytrichloride (freshly distilled, boiling point 105 to 107C) in 70 ml of absolute chloroform tdistilled for 90 minutes with circulation over P205) were placed in a round flask. At room temperature, nitrogen i was introduced into the solution for a short time to expel air.
The flask was equipped with a dropping funnel and sealed air-tight. While stirring by means of a magnetically operated stirrer, 20 mmol of the brominated alcohol of desired chain length in 50 ml of absolute chloroform were added dropwise slowly at room temperature with the exclusion of moisture.
Stirring was continued for about 12 hours. The hydrogen chloride resulting from the reaction as well as excess phosphorus oxytrichloride and chloroform were eliminated at 30C in the rotary evaporator. To eliminate every trace of phosphorus oxytrichloride toluene was added and likewise drained off.
: , : . :: - ~ - ~ :. . :
~:
: : .. , , 1063~31 HOE 74/B 036 The yield was 95 to 100~ and the conversion reaction can be checked by thin-layer chromatography.
Example 3 General preparation of alkylesters of phospholipid acid and of structural analogues thereof:
The phosporylation agent prepared in Example 1 or 2 (0.3 mol~ was dissolved in 100 ml of absolute chloroform (distilled for 90 minutes with circulation over P2O5), and the solution was cooled to 0 to 5C in an ice bath. While stirring by means o a magnetically operated stirrer, 60 g (0.6 mol) of absolute triethylamine tdried over lithiumaluminumhydrlde and freshly distilled) were added dropwise to 50 ml of absolute chloroform. The ice bath was then replaced by a water bath of 20C. While steadily stirring, a solution of the corresponding starting substance (0,15 mol) in 150 ml of absolute chloro-form was added dropwise to the phosporylation mixture.
Checking by means of thin-layer chromatography made sure that the reaction was almost complete already after the drop-wise addition. After another 6 hours at 40C the reaction mixture was freed in the rotary evaporator at 35C from solvent, and the residue was taken up in 450 ml of tetrahydro-furan. While stirring, 1 M sodium acetate solution of pH 8.4 ~ -,. .
. , . . .'. , ' :
' . , ' , , . . ' : ~' , ~0~3~3~ HOE 74/B 036 was added to the suspension or solution of the reaction ;
mixture in tetrahydrofuran until the water phase remained neutral (pH about 7). For this purpose, about 450 ml of lM sodium acetate solution had to be added. The hydrolysed reaction product was extracted as the sodium salt by means of 450 ml of diisopropylether. The water phase was again extracted by means of 200 ml of diisopropylether. The combined diisopropylether extracts were mixed while stirring with 10 g of sodium carbonate to eliminate water and to assure a `
complete conversion of the reaction product into the sodium salt.
For the preparation of derivatives having less than a total o 14 carbon atoms, the reaction solution was acidified with HCl (pH about 2) prior to the extraction with diisopropyl ether. Derivatives having a very short chain were better extxacted as the free acids and can be crystallized by care-fully adding sodium methylate in methanol.
The diisopropylether phase was filtered and the filtrate was evaporated in vacuo. The residue was recrystallized from ethylmethylketone/acetone mixtures~ Generally the resulting reaction products are analytically pure. Otherwise a complete purification of the products is brought about by chromato-graphy on silica gel. The yields of analytically pure product ~ -~
vary between 70 and 90% (calculated on the starting products ', ,' ' .: : . , :- : , . .
: , . , .. . . .
:: . ' , ' ~ . . . ' , :
1063~31 HOE 74/B 036 used).
The following compounds were prepared:
Compound of Group 1:
sn-1,2-dimyristoylglycerol-3-phosphoric acid methyl ester, as ' 32 62 8 (628.8) calculated: C 61.12% H9.94~ P 4.93%.
The data found complied with the calculated values.
Compound of Group 2:
sn-l-myristoylglycerol-3~phosphoric acid methyl ester, as sodium salt, C18H36NaO7P (418.5) calculated: C 51.67~ H 8.67% P 7.40%.
The data found complied with the calculated values.
Compound of Group 3:
1/2,3,4,5-pentapalmitoyl-D-mannitol-6-phosporic acid butyl ester, as sodium salt, C90Hl72NaOl4P (1532.3) calculated: C 70.55% H 11.32~ P 2.02%.
The data found complied with the calculated values.
Compound of Group 4:
/ Glyceroldioctyl etherphosphoric acid-(3)-~-bromoethyl ester, as sodium salt, C21H43BrNaO6P t525.5) calculated: C 48.00% H 8.25% Br 15,21% P 5.90%.
The data found complied with the calculated values.
Compound cf Group 5:
Diheptadecyl ketone glycerol-3-phosphoric acid octyl ester, as sodium salt, C46H92NaO6P (795.21) calculated: C 69.48% H 11.66% P 3.90%.
The data found complied with the calculated values.
Compound of Group 6:
Cyclopentadecyle ketone glycerol-3-phophoric acid-B-bromoethylester, , : . , . ,, ,~ . .:
::
- , . ~ , .
1~63~31 as sodium salt, C20H37BrNap (484-4) calculated: C 49,59~ H 7,70% Br 16,49~ P 6,39%.
The data found complied with the calculated values.
Compound of Group 7:
Oleoylhexanediol-(1,6)-phosphoric acid isopropyl ester, as sodium salt, C27H52NaO6P (526.68) calculated: C 61.57% H 9.52% P 5.88%.
The data found complied with the calculated values.
Compound of Group 8:
Propanediol-(1,3)-hexadecyl ether phosphoric acid hexyl ester, as sodium salt, C25H52NaO5P (486.7) calculated: C 61,70% EI 10,77% P 6,37%.
The data Eound complied with the calculated values.
, . -- 1 9 -- . .
_. .
, , " , .. . . . ~ . ,, :. , , - . : ,, , :
. . , . . , . , . . : . -.
Claims (26)
PROPERTY OR PRIVILEGE IS CLAIMED ARE DEFINED AS FOLLOWS:
1. A process for the preparation of a synthetic alkyl-ester of phospholipic acid, the structural analogues thereof and the physiologically acceptable salts thereof in which (A) a primary alcohol of the formula wherein R3 represents a saturated or unsaturated straight-chain or branched alkyl group of 1 to 25 carbon atoms, which may also be substituted by halogen, one or more cyclo-alkyl groups or one or more aromatic groups, is reacted with phosphorus oxychloride in the presence of an inert organic solvent, and (B) the resulting phosphorylation agent of the formula wherein R3 is as defined above, is reacted with a polyhydroxy compound, having up to 17 carbon atoms, having a free hydroxy group and the other hydroxy groups of which are protected, and, to produce a salt, the product may be reacted with a physiologi-cally acceptable reactant.
2. A process as claimed in claim 1, in which reaction (B) is carried out in the presence of an inert organic solvent.
3. A process as claimed in claim 1, in which reaction (B) is carried out in the presence of an organic base and with the exclusion of moisture.
4. A synthetic alkylester of phospholipid acid, the structural analogues and physiologically acceptable salts thereof, whenever obtained according to a process as claimed in claim 1, claim 2 or claim 3 or by an obvious chemical equivalent thereof.
5. A process as claimed in claim 1 in which in reaction (A) the solvent is selected from the group of chloroform and carbon tetrachloride.
6. A process as claimed in claim 1 in which in reaction (A) the molar ratio of alcohol to phosphorus oxychloride is in the range of from about 1:2.
7. A process as claimed in claim 1 in which reaction (A) is carried out under anhydrous conditions and at a temperature in the range of from -10 to +80°C.
8. A synthetic alkylester of phospholipid acid, the structural analogues and physiologically acceptable salts there-of, whenever obtained according to a process as claimed in claim 5, claim 6 or claim 7 or by an obvious chemical equivalent there-of.
9. A process as claimed in claim 1 for the preparation of an alkyl ester of phospholipid acid of the formula wherein R1 and R2 are identical or different and each represents a substituted or unsubstituted alkyl group having 5 to 25 car-baon atoms, and R3 is as defined in claim 1, the structural ana-longues thereof and the physiologically acceptable salts there-of in which (A) a primary alcohol of the formula R3OH wherein R3 is as de-fined in claim 1, is reacted with phosphorus-oxychloride in an inert organic solvent, and (B) the resulting phosphorylation agent is reacted with a poly-hydroxy compound having a free hydroxy group and the addi-tional hydroxy groups are protected and, to product a salt, the product may be reacted with a physiologically accept-able reactant.
10. An alkyl ester of phospholipid acid of the struc-tural formula as set forth in claim 9, whenever obtained ac-cording to a process as claimed in claim 9 or by an obvious chemical equivalent thereof.
11. A process as claimed in claim 1 for the preparation of sn-1,2-dimyristoylglycerol-3-phosphoric acid methylester in which methanol is reacted with phosphorus oxychloride in an inert organic solvent, the resultant methyl-phosphoric-acid-dichloride is reacted with 1,2-dimyristoyl-sn-glycerol in the presence of a base and the resultant product is subsequently isolated.
12. sn-1,2-Dimyristoylglycerol-3-phosphoric acid methyl-ester, whenever obtained according to a process as claimed in claim 11 or by an obvious chemical equivalent thereof.
13. A process as claimed in claim 1 for the preparation of sn-1-myristoylglycerol-3-phosphoric acid methylester in which methanol is reacted with phosphorus oxychloride in an inert organic solvent, the resultant methyl-phosphoric-acid-dichloride is reacted with 1-myristoyl-2-benzene-sn-glycerol in the presence of a base and the resultant product is subse-quently isolated.
14. sn-1-Myristoylglycerol-3-phosphoric acid methylester, whenever obtained according to a process as claimed in claim 13 or by an obivous chemical equivalent thereof.
15. A process as claimed in claim 1 for the preparation of 1,2,3,4,5-pentapalmitoyl-D-mannitol-6-phosphoric acid butyl-ester in which butanol is reacted with phosphorus oxychloride in an inert organic solvent, the resultant butyl-phosphoric-acid-dichloride is reacted with 1,2,3,4,5-pentapalmitoyl-D-mannitol in the presence of a base and the resultant product is isolated.
16. 1,2,3,4,5-Pentapalmitoyl-D-mannitol-6-phosphoric acid butyl-ester, whenever obtained according to a process as claimed in claim 15 or by an obvious chemical equivalent there-of.
17. A process as claimed in claim 1 for the preparation of glycerol dioctyl ether phosphoric acid-(3)-.beta.-bromoethylester in which bromoethyl alcohol is reacted with phosphorus oxychlor-ide in an inert organic solvent, the resultant bromoethyl-phos-phoric-acid-dichloride is reacted with 1,2-dioctyl-glycerol in the presence of a base and the product is subsequently isolated.
18. Glycerol dioctyl ether phosphoric acid-(3)-.beta.-bromo-ethylester, whenever obtained according to a process as claimed in claim 17 or by an obvious chemical equivalent thereof.
19. A process as claimed in claim 1 for the preparation of diheptadecyl ketoneglycerol-3-phosphoric acid octylester in which octanol is reacted with phosphorus oxychloride in an inert organic solvent, the resultant octyl-phosphoric-acid-dichloride is reacted with 1,2-diheptadecylketone-glycerol in the presence of a base and the product is subsequently isolated.
20. Diheptadecyl ketoneglycerol-3-phosphoric acid octy-ester, whenever obtained according to a process as claimed in claim 19 or by an obvious chemical equivalent thereof.
21. A process as claimed in claim 1 for the preparation of cyclopentadecyl ketoneglycerol-3-phosphoric acid-.beta.-bromoethyl-ester in which .beta.-bromoethanol is reacted with phosphorus oxy-chloride in an inert organic solvent, the result .beta.-bromoethyl-phosphoric acid-dichloride is reacted with cyclopentadecylketone-glycerol in the presence of a base and the product is subsequently isolated.
22. Cyclopentadecyl ketoneglycerol-3-phosphoric acid-.beta.-bromoethyl-ester, whenever obtained according to a process as claimed in claim 21 or by an obvious chemical equivalent there-of.
23. A process as claimed in claim 1 for the preparation of oleoyl-hexanediol-(1,6)-phosphoric acid isopropylester in which isopropyl alcohol is reacted with phosphorus oxychloride in an inert organic solvent, the resultant isopropyl-phosphoric-acid-dichloride is reacted with 1-oleoyl-hexanediol-(1,6) in the presence of a base and the product is subsequently isolated.
24. Oleoyl-hexanediol-(1,6)-phosphoric acid isopropyl-ester, whenever obtained according to a process as claimed in claim 23 or by an obvious chemical equivalent thereof.
25. A process as claimed in claim 1 for the preparation of propanediol-(1,3)-hexadecylether phosphoric acid hexylester in which hexanol is reacted with phosphorus oxychloride in an inert organic solvent, the resultant hexyl-phosphoric-acid-di-chloride is reacted with 1-hexadecyl-propanediol-(1,3) in the presence of a base and the resultant product is subsequently isolated.
26. Propanediol-(1,3)-hexadecylether phosphoric acid hexylester, whenever obtained according to a process as claimed in claim 25 or by an obvious chemical equivalent thereof.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE2437833A DE2437833A1 (en) | 1974-08-06 | 1974-08-06 | SYNTHETIC ALKYLESTERS OF PHOSPHATIC ACID AND STRUCTURAL ANALOGA, PROCESS FOR THEIR PRODUCTION AND USE |
Publications (1)
Publication Number | Publication Date |
---|---|
CA1063131A true CA1063131A (en) | 1979-09-25 |
Family
ID=5922579
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA232,800A Expired CA1063131A (en) | 1974-08-06 | 1975-08-05 | Synthetic alkyl esters of phospholipid acid, structural analogs thereof and a process for their manufacture and their use |
Country Status (13)
Country | Link |
---|---|
JP (1) | JPS5143724A (en) |
AU (1) | AU8368575A (en) |
BE (1) | BE832181A (en) |
CA (1) | CA1063131A (en) |
CH (1) | CH619962A5 (en) |
DE (1) | DE2437833A1 (en) |
DK (1) | DK355675A (en) |
FR (1) | FR2281374A1 (en) |
GB (1) | GB1523481A (en) |
IE (1) | IE41442B1 (en) |
IT (1) | IT1044019B (en) |
LU (1) | LU73149A1 (en) |
NL (1) | NL7509364A (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS56677Y2 (en) * | 1976-12-27 | 1981-01-09 | ||
DE3476770D1 (en) * | 1983-04-11 | 1989-03-23 | Meito Sangyo Kk | Production of primary or secondary alcohol derivatives of phospholipids by the enzymatic technique |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2750399A (en) * | 1949-12-27 | 1956-06-12 | Monsanto Chemicals | Process for alkyl phosphoryl dichlorides |
-
1974
- 1974-08-06 DE DE2437833A patent/DE2437833A1/en not_active Withdrawn
-
1975
- 1975-08-04 IT IT26085/75A patent/IT1044019B/en active
- 1975-08-05 IE IE1732/75A patent/IE41442B1/en unknown
- 1975-08-05 DK DK355675A patent/DK355675A/en unknown
- 1975-08-05 GB GB32665/75A patent/GB1523481A/en not_active Expired
- 1975-08-05 AU AU83685/75A patent/AU8368575A/en not_active Expired
- 1975-08-05 LU LU73149A patent/LU73149A1/xx unknown
- 1975-08-05 CA CA232,800A patent/CA1063131A/en not_active Expired
- 1975-08-06 BE BE158988A patent/BE832181A/en not_active IP Right Cessation
- 1975-08-06 NL NL7509364A patent/NL7509364A/en not_active Application Discontinuation
- 1975-08-06 CH CH1028475A patent/CH619962A5/en not_active IP Right Cessation
- 1975-08-06 FR FR7524488A patent/FR2281374A1/en active Granted
- 1975-08-06 JP JP50095096A patent/JPS5143724A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
IE41442L (en) | 1976-02-06 |
NL7509364A (en) | 1976-02-10 |
IE41442B1 (en) | 1980-01-02 |
BE832181A (en) | 1976-02-06 |
IT1044019B (en) | 1980-02-29 |
LU73149A1 (en) | 1977-04-13 |
DK355675A (en) | 1976-02-07 |
CH619962A5 (en) | 1980-10-31 |
JPS5143724A (en) | 1976-04-14 |
FR2281374A1 (en) | 1976-03-05 |
AU8368575A (en) | 1977-02-10 |
FR2281374B1 (en) | 1979-10-05 |
GB1523481A (en) | 1978-08-31 |
DE2437833A1 (en) | 1976-02-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4159988A (en) | Synthetic phospholipids, a process for their manufacture and their use | |
Yuan et al. | Synthesis and evaluation of phospholipid analogs as inhibitors of cobra venom phospholipase A2 | |
Eibl et al. | Synthesis of enantiomerically pure glyceryl esters and ethers. I. Methods employing the precursor 1, 2-isopropylidene-sn-glycerol | |
US4873355A (en) | Process for regioselectively preparing phosphorylated inositols and other cyclitols | |
WO2013071418A1 (en) | Methods for the synthesis of plasmalogens and plasmalogen derivatives, and therapeutic uses thereof | |
EP0524979A4 (en) | 2(5h)-furanones substituted in the 5 and or in the 4 position, as anti-inflammatory agents | |
EP0036583A2 (en) | Glycerine-3-phosphoric acid halogenalkyl ester, process for its preparation and further processing | |
CA1063615A (en) | Synthetic phospholipids, a process for their manufacture and their use | |
US4163748A (en) | Propane-1,3-diol phosphatides and method of preparing the same | |
CA1063131A (en) | Synthetic alkyl esters of phospholipid acid, structural analogs thereof and a process for their manufacture and their use | |
Baer et al. | Synthesis of unsaturated α-phosphatidic acids and α-bisphosphatidic acids. Cardiolipin substitutes. IV | |
US4160773A (en) | Synthetic alkyl esters of phospholipid acid, structural analogs thereof and a process for their manufacture and their use | |
US5081147A (en) | 4-(1-hydroxy-2-substituted amino)ethyl-5-hydroxy-2(5H)-furanones as anti-inflammatory agents | |
US4751320A (en) | Phosphoric ester and process for producing same | |
US3632692A (en) | Organophosphorus anhydrides | |
WO1992019609A1 (en) | Substituted dihydroxy-bis-[5-hydroxy-2(5h)-furanone-4-yl]-alkanes as anti-inflammatory agents | |
GB1581810A (en) | Process for the preparation of phospholipids | |
JP4677550B2 (en) | Cyclic ester compound | |
Liu et al. | Synthesis of novel chiral 2‐oxo‐and 2‐thio‐1, 3, 2‐oxazaphospholidines via asymmetric cyclization of l‐methionol with (thio) phosphoryl dichlorides | |
EP0043472B1 (en) | 3-hydrocarbylthio-2-acyloxypropyl 2-trimethylammonioethyl phosphates, process for producing the same and pharmaceutical preparations containing the same | |
Massing et al. | Synthesis of enantiomerically pure 1-O-phosphocholine-2-O-acyl-octadecane and 1-O-phosphocholine-2-N-acyl-octadecane | |
JPH06228169A (en) | Production of 1-o-acylglycerol 2,3-phosphate | |
Garcia et al. | Synthesis of new ether glycerophospholipids structurally related to modulator | |
EP0372941A2 (en) | Anti-inflammatory 5-hydroxy-2-furanones | |
US4740609A (en) | Phosphoric esters and process for preparing same |